National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 54225 [2022-19054]

Download as PDF Federal Register / Vol. 87, No. 170 / Friday, September 2, 2022 / Notices from approximately 9 a.m. to 5 p.m. ET (times are tentative and subject to change) each day. The confirmed times and agenda items for the meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2022-10-04/ when this information becomes available. FOR FURTHER INFORMATION CONTACT: lotter on DSK11XQN23PROD with NOTICES1 James Berger, Designated Federal Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L600, Washington, DC 20024. Email: tickbornedisease@ hhs.gov. Phone: 202–795–7608. Dated: August 23, 2022. James J. Berger, Designated Federal Officer, Tick-Borne Disease Working Group, Office of Infectious Disease and HIV/AIDS Policy. [FR Doc. 2022–18972 Filed 9–1–22; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the SUPPLEMENTARY INFORMATION: A link to following meeting. view the webcast can be found on the The meeting will be closed to the meeting website at https://www.hhs.gov/ public in accordance with the ash/advisory-committees/ provisions set forth in sections tickbornedisease/meetings/2022-10-04/ 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., index.html when it becomes available. as amended. The grant applications and The public will have an opportunity to present their views to the TBDWG orally the discussions could disclose confidential trade secrets or commercial during the meeting’s public comment property such as patentable material, session or by submitting a written and personal information concerning public comment. Comments should be individuals associated with the grant pertinent to the meeting discussion. applications, the disclosure of which Persons who wish to provide verbal or would constitute a clearly unwarranted written public comment should review invasion of personal privacy. instructions at https://www.hhs.gov/ ash/advisory-committees/ Name of Committee: Microbiology, tickbornedisease/meetings/2022-10-04/ Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases index.html and respond by midnight B Research Study Section Microbiology and September 26, 2022 ET. Verbal Infectious Diseases B Research Study comments will be limited to three Section. minutes each to accommodate as many Date: October 26–27, 2022. speakers as possible during the 30Time: 11:00 a.m. to 5:30 p.m. minute session. Written public Agenda: To review and evaluate grant comments will be accessible to the public on the TBDWG web page prior to applications. Place: National Institute of Allergy and the meeting. Infectious Diseases, National Institutes of Background and Authority: The Tick- Health, 5601 Fishers Lane, Room 3F58, Borne Disease Working Group was Rockville, MD 20892 (Virtual Meeting). established on August 10, 2017, in Contact Person: Mario Cerritelli, Ph.D., Scientific Review Officer, National Institute accordance with Section 2062 of the 21st Century Cures Act, and the Federal of Allergy and Infectious Diseases, National Advisory Committee Act, 5 U.S.C. App., Institutes of Health, 5601 Fishers Lane, Room 3F58, Rockville, MD 20892, 240–669–5199, as amended, to provide expertise and cerritem@mail.nih.gov. review federal efforts related to all tick(Catalogue of Federal Domestic Assistance borne diseases, to help ensure Program Nos. 93.855, Allergy, Immunology, interagency coordination and minimize and Transplantation Research; 93.856, overlap, and to examine research Microbiology and Infectious Diseases priorities. The TBDWG is required to Research, National Institutes of Health, HHS) submit a report to the HHS Secretary Dated: August 30, 2022. and Congress on their findings and any recommendations for the federal Tyeshia M. Roberson-Curtis, response to tick-borne disease every two Program Analyst, Office of Federal Advisory years. Committee Policy. [FR Doc. 2022–19054 Filed 9–1–22; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 16:40 Sep 01, 2022 Jkt 256001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 54225 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed). Date: September 30, 2022. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific Review Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892, 301–761–7176, dimitrios.vatakis@ nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed). Date: October 4, 2022. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dimitrios N. Vatakis, Ph.D., Scientific Review Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892, 301–761–7176, dimitrios.vatakis@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\02SEN1.SGM 02SEN1

Agencies

[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Page 54225]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group; Microbiology and Infectious Diseases B 
Research Study Section Microbiology and Infectious Diseases B 
Research Study Section.
    Date: October 26-27, 2022.
    Time: 11:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F58, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mario Cerritelli, Ph.D., Scientific Review 
Officer, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F58, 
Rockville, MD 20892, 240-669-5199, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 30, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19054 Filed 9-1-22; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.